Literature DB >> 18347037

A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence.

Jeroen P J Saeij1, Gustavo Arrizabalaga, John C Boothroyd.   

Abstract

Toxoplasma gondii is one of the most successful protozoan parasites of warm-blooded animals. Stage-specific expression of its surface molecules is thought to be key to its ability to establish chronic infection in immunocompetent animals. The rapidly dividing tachyzoite stage displays a different subset of family of surface antigen 1 (SAG1)-related sequences (SRSs) from that displayed by the encysted bradyzoite stage. It is possible that this switch is necessary to protect the bradyzoites against an immune response raised against the tachyzoite stage. Alternatively, it might be that bradyzoite SRSs evolved to facilitate invasion of different cell types, such as those found in the brain, where cysts develop, or the small intestine, where bradyzoites must enter after oral infection. Here we studied the function of a cluster of four tandem genes, encoding bradyzoite SRSs called SAG2C, -D, -X, and -Y. Using bioluminescence imaging of mice infected with parasites expressing firefly luciferase (FLUC) driven by the SAG2D promoter, we show stage conversion for the first time in living animals. A truncated version of the SAG2D promoter (SAG2Dmin) gave efficient expression of FLUC in both tachyzoites and bradyzoites, indicating that the bradyzoite specificity of the complete SAG2D promoter is likely due to an element(s) that normally suppresses expression in tachyzoites. Comparing mice infected with the wild type or a mutant where the SAG2CDXY cluster of genes has been deleted (DeltaSAG2CDXY), we demonstrate that whereas DeltaSAG2CDXY parasites are less capable of maintaining a chronic infection in the brain, they do not show a defect in oral infectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347037      PMCID: PMC2423105          DOI: 10.1128/IAI.01494-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Targeted disruption of the glycosylphosphatidylinositol-anchored surface antigen SAG3 gene in Toxoplasma gondii decreases host cell adhesion and drastically reduces virulence in mice.

Authors:  F Dzierszinski; M Mortuaire; M F Cesbron-Delauw; S Tomavo
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

2.  The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans.

Authors:  A Jacquet; L Coulon; J De Nève; V Daminet; M Haumont; L Garcia; A Bollen; M Jurado; R Biemans
Journal:  Mol Biochem Parasitol       Date:  2001-08       Impact factor: 1.759

3.  Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction.

Authors:  Upinder Singh; Jeremy L Brewer; John C Boothroyd
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

4.  Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression.

Authors:  Michael D Cleary; Upinder Singh; Ira J Blader; Jeremy L Brewer; John C Boothroyd
Journal:  Eukaryot Cell       Date:  2002-06

5.  Toxoplasma gondii major surface antigen (SAG1): in vitro analysis of host cell binding.

Authors:  S A Robinson; J E Smith; P A Millner
Journal:  Parasitology       Date:  2004-04       Impact factor: 3.234

6.  The SRS superfamily of Toxoplasma surface proteins.

Authors:  Calvin Jung; Cleo Y-F Lee; Michael E Grigg
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

7.  Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine.

Authors:  Seon-Kyeong Kim; Ariela Karasov; John C Boothroyd
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

8.  Analysis by immunoblotting of Toxoplasma gondii exo-antigens and comparison with somatic antigens.

Authors:  M H Bessières; S Le Breton; J P Séguéla
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

9.  Structure of the immunodominant surface antigen from the Toxoplasma gondii SRS superfamily.

Authors:  Xiao-lin He; Michael E Grigg; John C Boothroyd; K Christopher Garcia
Journal:  Nat Struct Biol       Date:  2002-08

10.  Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulins G, M, and A antibodies at different stages of infection.

Authors:  P Partanen; H J Turunen; R T Paasivuo; P O Leinikki
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

View more
  35 in total

1.  Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

2.  Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.

Authors:  Tze Guan Tan; Ernest Mui; Hua Cong; William H Witola; Alexandre Montpetit; Stephen P Muench; John Sidney; Jeff Alexander; Alessandro Sette; Michael E Grigg; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-03-26       Impact factor: 3.641

Review 3.  Advances in bioluminescence imaging of live animal models.

Authors:  Robin S Dothager; Kelly Flentie; Britney Moss; Mei-Hsiu Pan; Aparna Kesarwala; David Piwnica-Worms
Journal:  Curr Opin Biotechnol       Date:  2009-02-23       Impact factor: 9.740

Review 4.  Toxoplasma gondii: 25 years and 25 major advances for the field.

Authors:  John C Boothroyd
Journal:  Int J Parasitol       Date:  2009-07-01       Impact factor: 3.981

5.  Bradyzoite pseudokinase 1 is crucial for efficient oral infectivity of the Toxoplasma gondii tissue cyst.

Authors:  Kerry R Buchholz; Paul W Bowyer; John C Boothroyd
Journal:  Eukaryot Cell       Date:  2013-01-04

6.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

7.  Detection of antibodies to Toxoplasma gondii in domesticated ruminants by recombinant truncated SAG2 enzyme-linked immunosorbent assay.

Authors:  Harkirat Singh; Anup Kumar Tewari; Ashok Kumar Mishra; Biswaranjan Maharana; Vikrant Sudan; Opinder Krishan Raina; Jammi Raghavendra Rao
Journal:  Trop Anim Health Prod       Date:  2014-10-16       Impact factor: 1.559

Review 8.  Observations on bradyzoite biology.

Authors:  Vincent Tu; Rama Yakubu; Louis M Weiss
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

9.  Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Immunome Res       Date:  2010-12-03

10.  Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole.

Authors:  Aliaksandr Khaminets; Julia P Hunn; Stephanie Könen-Waisman; Yang O Zhao; Daniela Preukschat; Jörn Coers; Jon P Boyle; Yi-Ching Ong; John C Boothroyd; Gabriela Reichmann; Jonathan C Howard
Journal:  Cell Microbiol       Date:  2010-01-26       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.